1. U.S. Department of Health & Human Services, Food and Drug Administration. FDA: possible fracture risk with high dose, long-term use of proton pump inhibitors. https://wayback.archive-it.org/7993/20170112031951/ http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2010/ucm213377.htm. Updated 04/23/2013. Accessed January 1, 2020.
2. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients;Corley;Gastroenterology,2010
3. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the women's health initiative;Gray;Arch Intern Med,2010
4. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors;Kaye;Pharmacotherapy,2008
5. Use of proton pump inhibitors and risk of osteoporosis-related fractures;Targownik;CMAJ,2008